FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079477603> ?p ?o ?g. }

• W2079477603 endingPage "27" @default.
• W2079477603 startingPage "19" @default.
• W2079477603 abstract "BackgroundCombined superficial femoral artery (SFA) and tibial angioplasty (TA) are a common treatment for critical limb ischemia. Poor tibial runoff significantly compromises durability and clinical effectiveness of SFA interventions. The aim of this study is to determine clinical and anatomic outcomes of SFA interventions in patients with equally compromised runoff, with and without concomitant TA.MethodsThe database of patients undergoing endovascular treatment of SFA (1999-2009) was retrospectively queried. Patients with poor runoff, scored >10 by modified Society for Vascular Surgery criteria, were selected. Preoperative angiograms were reviewed to assess distal popliteal and tibial runoff. Kaplan-Meier analyses were performed to assess time-dependent outcomes. Factor analyses were performed for time-dependent variables.ResultsA total of 162 limbs with a runoff score >10 (56% men; average age, 69 years) underwent endovascular intervention for symptomatic SFA disease: 61 (54% men) underwent TA but the remaining 101 (57% men) did not. The groups were matched for age, sex, and SFA anatomy (Trans-Atlantic Inter-Society Consensus II C/D lesions: 56% no TA vs 62% TA; P = .5). Presenting symptoms were similar between no TA and TA groups (rest pain: 40% vs 32%; tissue loss: 60% vs 68%; P = .3). Three-year survival favored the TA group (79% ± 5%) vs no TA (68% ± 5%; P = .06). Three-year anatomic outcomes in no TA vs TA group, including primary patency (45% ± 6% vs 63% ± 8%; P = .04), assisted primary patency (55% ± 6% vs 75% ± 7%; P = .03), and secondary patency (57% ± 6% vs 77% ± 7%; P = .03) were all superior in the TA group. Target vessel revascularization in no TA vs TA (61% ± 6% vs 74% ± 8%; P = .002) and target extremity revascularization (42% ± 6% vs 59% ± 8%; P = .06) also favored the TA group. However the comparison of no TA vs TA for clinical success (39% ± 6% vs 47% ± 8%; P = .6), freedom from recurrent symptoms (59% ± 6%vs 60% ± 9%; P = .1), amputation-free survival (46% ± 5% vs 63% ± 7%; P = .06), and limb salvage at 3 years (63% ± 6% vs 74% ± 7%; P = .6) were similar.ConclusionsTA in patients with poor runoff has a positive effect on SFA anatomic outcomes. However, clinical success was not affected. Concomitant TA appears not to add clinical benefit to SFA intervention in critical limb ischemia. Combined superficial femoral artery (SFA) and tibial angioplasty (TA) are a common treatment for critical limb ischemia. Poor tibial runoff significantly compromises durability and clinical effectiveness of SFA interventions. The aim of this study is to determine clinical and anatomic outcomes of SFA interventions in patients with equally compromised runoff, with and without concomitant TA. The database of patients undergoing endovascular treatment of SFA (1999-2009) was retrospectively queried. Patients with poor runoff, scored >10 by modified Society for Vascular Surgery criteria, were selected. Preoperative angiograms were reviewed to assess distal popliteal and tibial runoff. Kaplan-Meier analyses were performed to assess time-dependent outcomes. Factor analyses were performed for time-dependent variables. A total of 162 limbs with a runoff score >10 (56% men; average age, 69 years) underwent endovascular intervention for symptomatic SFA disease: 61 (54% men) underwent TA but the remaining 101 (57% men) did not. The groups were matched for age, sex, and SFA anatomy (Trans-Atlantic Inter-Society Consensus II C/D lesions: 56% no TA vs 62% TA; P = .5). Presenting symptoms were similar between no TA and TA groups (rest pain: 40% vs 32%; tissue loss: 60% vs 68%; P = .3). Three-year survival favored the TA group (79% ± 5%) vs no TA (68% ± 5%; P = .06). Three-year anatomic outcomes in no TA vs TA group, including primary patency (45% ± 6% vs 63% ± 8%; P = .04), assisted primary patency (55% ± 6% vs 75% ± 7%; P = .03), and secondary patency (57% ± 6% vs 77% ± 7%; P = .03) were all superior in the TA group. Target vessel revascularization in no TA vs TA (61% ± 6% vs 74% ± 8%; P = .002) and target extremity revascularization (42% ± 6% vs 59% ± 8%; P = .06) also favored the TA group. However the comparison of no TA vs TA for clinical success (39% ± 6% vs 47% ± 8%; P = .6), freedom from recurrent symptoms (59% ± 6%vs 60% ± 9%; P = .1), amputation-free survival (46% ± 5% vs 63% ± 7%; P = .06), and limb salvage at 3 years (63% ± 6% vs 74% ± 7%; P = .6) were similar. TA in patients with poor runoff has a positive effect on SFA anatomic outcomes. However, clinical success was not affected. Concomitant TA appears not to add clinical benefit to SFA intervention in critical limb ischemia." @default.
• W2079477603 created "2016-06-24" @default.
• W2079477603 creator A5003202081 @default.
• W2079477603 creator A5027120100 @default.
• W2079477603 creator A5039311069 @default.
• W2079477603 creator A5076355638 @default.
• W2079477603 creator A5077166214 @default.
• W2079477603 creator A5078951381 @default.
• W2079477603 date "2013-01-01" @default.
• W2079477603 modified "2023-09-30" @default.
• W2079477603 title "Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia" @default.
• W2079477603 cites W1967179207 @default.
• W2079477603 cites W1977502781 @default.
• W2079477603 cites W1978041581 @default.
• W2079477603 cites W1979219809 @default.
• W2079477603 cites W1980564242 @default.
• W2079477603 cites W1991257759 @default.
• W2079477603 cites W1998812695 @default.
• W2079477603 cites W2001031589 @default.
• W2079477603 cites W2015619424 @default.
• W2079477603 cites W2015745956 @default.
• W2079477603 cites W2017483184 @default.
• W2079477603 cites W2024985270 @default.
• W2079477603 cites W2033417434 @default.
• W2079477603 cites W2035006751 @default.
• W2079477603 cites W2039948180 @default.
• W2079477603 cites W2043517681 @default.
• W2079477603 cites W2046953232 @default.
• W2079477603 cites W2048001335 @default.
• W2079477603 cites W2058937975 @default.
• W2079477603 cites W2067506236 @default.
• W2079477603 cites W2071356282 @default.
• W2079477603 cites W2073595207 @default.
• W2079477603 cites W2081954992 @default.
• W2079477603 cites W2084838672 @default.
• W2079477603 cites W2088166517 @default.
• W2079477603 cites W2118337157 @default.
• W2079477603 cites W2123037059 @default.
• W2079477603 cites W2131845321 @default.
• W2079477603 cites W2145994607 @default.
• W2079477603 cites W2185467918 @default.
• W2079477603 cites W2796129716 @default.
• W2079477603 cites W4241006846 @default.
• W2079477603 doi "https://doi.org/10.1016/j.jvs.2012.06.110" @default.
• W2079477603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23158842" @default.
• W2079477603 hasPublicationYear "2013" @default.
• W2079477603 type Work @default.
• W2079477603 sameAs 2079477603 @default.
• W2079477603 citedByCount "14" @default.
• W2079477603 countsByYear W20794776032013 @default.
• W2079477603 countsByYear W20794776032014 @default.
• W2079477603 countsByYear W20794776032018 @default.
• W2079477603 countsByYear W20794776032019 @default.
• W2079477603 countsByYear W20794776032020 @default.
• W2079477603 countsByYear W20794776032021 @default.
• W2079477603 countsByYear W20794776032022 @default.
• W2079477603 countsByYear W20794776032023 @default.
• W2079477603 crossrefType "journal-article" @default.
• W2079477603 hasAuthorship W2079477603A5003202081 @default.
• W2079477603 hasAuthorship W2079477603A5027120100 @default.
• W2079477603 hasAuthorship W2079477603A5039311069 @default.
• W2079477603 hasAuthorship W2079477603A5076355638 @default.
• W2079477603 hasAuthorship W2079477603A5077166214 @default.
• W2079477603 hasAuthorship W2079477603A5078951381 @default.
• W2079477603 hasBestOaLocation W20794776031 @default.
• W2079477603 hasConcept C118552586 @default.
• W2079477603 hasConcept C126322002 @default.
• W2079477603 hasConcept C141071460 @default.
• W2079477603 hasConcept C27415008 @default.
• W2079477603 hasConcept C2777010666 @default.
• W2079477603 hasConcept C2777466421 @default.
• W2079477603 hasConcept C2778789114 @default.
• W2079477603 hasConcept C2779384505 @default.
• W2079477603 hasConcept C2779723990 @default.
• W2079477603 hasConcept C2780326628 @default.
• W2079477603 hasConcept C2781099653 @default.
• W2079477603 hasConcept C3018348675 @default.
• W2079477603 hasConcept C541997718 @default.
• W2079477603 hasConcept C71924100 @default.
• W2079477603 hasConceptScore W2079477603C118552586 @default.
• W2079477603 hasConceptScore W2079477603C126322002 @default.
• W2079477603 hasConceptScore W2079477603C141071460 @default.
• W2079477603 hasConceptScore W2079477603C27415008 @default.
• W2079477603 hasConceptScore W2079477603C2777010666 @default.
• W2079477603 hasConceptScore W2079477603C2777466421 @default.
• W2079477603 hasConceptScore W2079477603C2778789114 @default.
• W2079477603 hasConceptScore W2079477603C2779384505 @default.
• W2079477603 hasConceptScore W2079477603C2779723990 @default.
• W2079477603 hasConceptScore W2079477603C2780326628 @default.
• W2079477603 hasConceptScore W2079477603C2781099653 @default.
• W2079477603 hasConceptScore W2079477603C3018348675 @default.
• W2079477603 hasConceptScore W2079477603C541997718 @default.
• W2079477603 hasConceptScore W2079477603C71924100 @default.
• W2079477603 hasIssue "1" @default.
• W2079477603 hasLocation W20794776031 @default.
• W2079477603 hasLocation W20794776032 @default.
• W2079477603 hasOpenAccess W2079477603 @default.
• W2079477603 hasPrimaryLocation W20794776031 @default.

• next